TNM Classification of Malignant Tumours eighth edition provides the latest, internationally agreed-upon standards to describe and categorize cancer stage.
* Published in affiliation with the Union for International Cancer Control (UICC)
* Arranged by anatomical region, this authoritative pocket sized guide contains many important updated organ-specific classifications
* There are new classifications for p16 positive oropharyngeal carcinomas, carcinomas of the thymus, neuroendocrine tumours of the pancreas, and sarcomas
* To facilitate the collection of stage data for cancer surveillance in low and middle income countries there are new sections on Essential TNM and Paediatric Cancer Stage
* New colour presentation
TNM Classification of Malignant Tumours, 8th edition is available as an app for i OS and Android. This Wiley app-book is developed by Med Hand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Med Hand’s patented technology.
Spis treści
Preface XII
Acknowledgments XIV
Organizations Associated with the TNM System XV
Members of UICC Committees Associated with the TNM System XVI
Section Editors XVII
Introduction 1 Head and Neck Tumours 17
Lip and Oral Cavity 18
Pharynx 22
Larynx 31
Nasal Cavity and Paranasal Sinuses 36
Unknown Primary – Cervical Nodes 40
Malignant Melanoma of Upper Aerodigestive Tract 45
Major Salivary Glands 47
Thyroid Gland 51
Digestive System Tumours 55
Oesophagus and Oesophagogastric Junction 57
Stomach 63
Small Intestine 67
Appendix 70
Colon and Rectum 73
Anal Canal and Perianal Skin 77
Liver 80
Intrahepatic Bile Ducts 83
Gallbladder 85
Perihilar Bile Ducts 87
Distal Extrahepatic Bile Duct 89
Ampulla of Vater 91
Pancreas 93
Well-Differentiated Neuroendocrine Tumours of the Gastrointestinal Tract 96
Lung, Pleural, and Thymic Tumours 105
Lung 106
Pleural Mesothelioma 113
Thymic Tumours 115
Tumours of Bone and Soft Tissues 119
Bone 120
Soft Tissues 124
Gastrointestinal Stromal Tumour (GIST) 127
Skin Tumours 131
Carcinoma of Skin 133
Skin Carcinoma of the Head and Neck 136
Carcinoma of Skin of the Eyelid 139
Malignant Melanoma of Skin 142
Merkel Cell Carcinoma of Skin 147
Breast Tumours 151
Gynaecological Tumours 159
Vulva 161
Vagina 164
Cervix Uteri 166
Uterus – Endometrium 171
Uterine Sarcomas 175
Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma 179
Gestational Trophoblastic Neoplasms 184
Urological Tumours 187
Penis 188
Prostate 191
Testis 195
Kidney 199
Renal Pelvis and Ureter 202
Urinary Bladder 204
Urethra 208
Adrenal Cortex 211
Ophthalmic Tumours 215
Carcinoma of Conjunctiva 216
Malignant Melanoma of Conjunctiva 218
Malignant Melanoma of Uvea 221
Retinoblastoma 226
Sarcoma of Orbit 230
Carcinoma of Lacrimal Gland 232
Hodgkin Lymphoma 235
Non-Hodgkin Lymphomas 239
Essential TNM 241
Paediatric Tumours 247
Gastrointestinal Tumours 247
Bone and Soft Tissue Tumours 248
Gynaecological Tumours 249
Urological Tumours 250
Ophthalmic Tumours 251
Malignant Lymphoma 252
Central Nervous System 252
O autorze
James D. Brierley, BSc, MB, FRCP, FRCR, FRCPC
Professor, Department of Radiation Oncology, Princess Margaret Cancer Centre and the University of Toronto, Canada
Dr Brierley trained in Clinical Oncology in the UK and developed his interest in cancer staging and surveillance when moving to Canada and has been involved in cancer surveillance, locally, nationally and internationally. He is Co-Chair of the UICC TNM Prognostic Factors Project. He has co-edited the TNM Supplement 4th edition (Wiley 2012) and the UICC Manual of Clinical Oncology (Wiley 2015).
Mary K. Gospodarowicz MD, FRCPC, FRCR (Hon)
Medical Director, Princess Margaret Cancer Centre, University Health Network; Regional Vice-President of Cancer Care Ontario for Toronto South; Toronto, Ontario, Canada
Dr Gospodarowicz is the Past-President of UICC. She has a long-standing interest in cancer classification with an emphasis on staging and prognostic factors and she has been involved in the UICC TNM Project for many years. Her interests include the application of modern information and communication technologies in cancer control. Dr Gospodarowicz was coeditor of the 7th edition of the TNM Classification of Malignant Tumours (Wiley 2009) and editor of the 2nd and 3rd editions of the UICC Prognostic Factors in Cancer (Wiley 2001, 2006).
Christian Wittekind MD
Professor of Pathology, Chairman Institute of Pathology, University of Leipzig, Germany
Dr Wittekind been involved in cancer staging and tumour classifications for over 20 years. He is a member of the UICC TNM Core Committee, Head of the German Speaking TNM-Komittee, and personally responds to all the questions to the UICC TNM helpdesk. He was the coeditor of the 5th , 6th and 7th edition of the TNM classification of Malignant Tumours (Wiley 1997, 2002, 2009) editor of the 2nd, 3rd, and 4th edition of the TNM Supplement (Wiley 2001, 2003 and 2012) and editor of the 6th edition of the TNM Atlas (Wiley 2014).